Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC
Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC
Not yet recruiting · NCT07698106 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-28 | NCT07698106 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Buzzard Pharmaceuticals | 2 |
| University Health Network, Toronto | 417 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||